Citadel Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 7130 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7042 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6870 |
|
|
2024
Q3 | – | Sell |
-280
| Closed | -$4.88K | – | 6821 |
|
|
2024
Q2 | $4.88K | Sell |
280
-25,148
| -99% | -$438K | ﹤0.01% | 5590 |
|
|
2024
Q1 | $1.06M | Sell |
25,428
-32,174
| -56% | -$1.34M | ﹤0.01% | 3124 |
|
|
2023
Q4 | $1.45M | Sell |
57,602
-2,352
| -4% | -$59.2K | ﹤0.01% | 2688 |
|
|
2023
Q3 | $1.96M | Sell |
59,954
-42,503
| -41% | -$1.39M | ﹤0.01% | 2405 |
|
|
2023
Q2 | $5.96M | Buy |
102,457
+101,858
| +17,005% | +$5.93M | ﹤0.01% | 1582 |
|
|
2023
Q1 | $15.6K | Sell |
599
-30,896
| -98% | -$806K | ﹤0.01% | 5440 |
|
|
2022
Q4 | $938K | Buy |
+31,495
| New | +$938K | ﹤0.01% | 3273 |
|
|
2022
Q3 | – | Sell |
-1,508
| Closed | -$44K | – | 6804 |
|
|
2022
Q2 | $44K | Sell |
1,508
-342
| -18% | -$9.98K | ﹤0.01% | 5542 |
|
|
2022
Q1 | $97K | Sell |
1,850
-740
| -29% | -$38.8K | ﹤0.01% | 5667 |
|
|
2021
Q4 | $178K | Buy |
2,590
+1,459
| +129% | +$100K | ﹤0.01% | 5557 |
|
|
2021
Q3 | $180K | Sell |
1,131
-438
| -28% | -$69.7K | ﹤0.01% | 5499 |
|
|
2021
Q2 | $306K | Buy |
+1,569
| New | +$306K | ﹤0.01% | 5186 |
|
|
2020
Q2 | – | Sell |
-387
| Closed | -$116K | – | 5381 |
|
|
2020
Q1 | $116K | Buy |
+387
| New | +$116K | ﹤0.01% | 4306 |
|